Evaluating serum biomarkers liverfast surrogates of liver fibrosis and steatosis could identify risks in a clinical population experiencing SARS-COV2 infection (COVID)

Category Primary study
JournalHepatology
Year 2020
This article has no abstract
Epistemonikos ID: 578c1a17ddca208d5677a3a5417780accce4bdc1
First added on: Dec 17, 2020